Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Absci Corporation announced plans for a global, multi-center Phase 2 STORYLINE clinical trial to evaluate the efficacy and safety of ABS-201, an AI-designed anti-prolactin receptor antibody, for treating moderate to severe endometriosis-associated pain. The double-blind, placebo-controlled trial is planned to start in mid-2027, enrolling about 150 …
Milestone Pharmaceuticals has enrolled the first patient in Canada for the ReVeRA-301 Phase 3 pivotal trial evaluating their FDA-approved etripamil nasal spray, CARDAMYST, for treatment of atrial fibrillation with rapid ventricular rate (AFib-RVR). This multinational trial aims to enroll 150 patients to assess the efficacy of self-administered etri…
Cronos Group Inc., a global cannabis company, held its first Investor Day at its Kingsville location showcasing its commitment to research, development, and innovation through its diverse international cannabis brands. The event was webcast with presentations made available to investors.
Chaince Digital Holdings Inc., a Nasdaq-listed digital finance and technology company, completed a transaction repurchasing and permanently canceling all outstanding warrants issued in a private placement. The company paid $2 million in cash to warrant holders, eliminating potential dilution as no new shares were issued or reserved. This move simpl…
VisionWave Holdings, Inc. disclosed a purchase order valued at $20 million from Metal Machinery Components Trading FZCO for 200 STRATUM VARAN unmanned ground vehicles. The order's execution is contingent upon multiple conditions, including advance payment, financing proof, regulatory approvals, export licenses, and compliance reviews. Delivery is p…
Terra Innovatum, a Nasdaq-listed company developing the SOLO™ Micro-Modular Reactor, applauds Italy's parliamentary approval of legislation restoring nuclear energy use, creating a new market for advanced nuclear technologies. The legislation supports sustainable nuclear power including small modular reactors, strengthening energy security and deca…
Mitek is a cash-positive identity-verification vendor trading below its 52-week high while short interest remains elevated. We lay out a mid-term swing trade (45 trading days) to capture both fundamental re-rating and a potential short-covering rally, with strict risk controls.
Nexentis Technologies Inc. has appointed Professor Dan T. Major to the Scientific Advisory Board of its wholly owned subsidiary, MitoCareX Bio Ltd. Prof. Major, an expert in computational chemistry and in silico drug discovery, will advise MitoCareX as it expands its computational drug discovery capabilities to enhance prioritization of its researc…
3 E Network Technology Group Limited announces a strategic partnership with HashBeaver to leverage a token-based Web3 payment gateway for its Finnish green AI compute center. This collaboration aims to broaden global market reach by enabling decentralized AI developers and communities to access compute resources via blockchain-based on-chain settle…
Sky Quarry Inc. announced the restart of its Eagle Springs Refinery in Nevada following approval of an air permit by the Nevada Division of Environmental Protection. The refinery, operated by Sky Quarry's subsidiary Foreland Refining Corporation, has a capacity of approximately 5,000 barrels per day. The company completed $300,000 in upgrades and p…
Liberty Global's operating units have steady cash generation and a recent move by Ziggo to accelerate deleveraging meaningfully reduces execution risk for a 2027 value-unlock event. At $12.41 the shares trade below book and well under the 2026 peak; this trade targets $20 while limiting downside to $10.20 if the macro or integration story derails.
Navios Maritime Partners has more than doubled off its 52-week low and is trading cheaply on headline multiples. With $3.9 billion of contracted revenue, recurring distributions and recent successful bond placements, NMM looks positioned for further upside. We lay out an actionable long trade with entry, stop and target, and explain the drivers and…
Streamex Corp. announced that a leading institutional investment manager has launched a gold-denominated delta-neutral strategy using GLDY, its gold-backed tokenized asset, with an initial investment of $1 million. This marks a significant milestone as Streamex meets its ninety-day objective to convert institutional allocations into GLDY, potential…
Profusa, Inc. announced progress in its quality management certification under ISO 13485 through GMED, moving closer to obtaining MDR conformity assessment and CE marking for its Lumee Oxygen Platform, a biosensor technology for continuous tissue oxygen monitoring. This milestone reflects enhanced compliance with European medical device regulations…
Kala Bio and Virotek have signed a non-binding letter of intent with a U.S. DNA testing platform to resell Virotek's genetic testing products, potentially expanding distribution beyond ophthalmology and creating new commercial channels. The agreement is still subject to finalization of terms and definitive agreements. Kala anticipates this could ge…
Immuneering Corporation announced that data from its ongoing Phase 3 MAPKeeper 301 trial evaluating atebimetinib in combination with chemotherapy for first-line treatment of metastatic pancreatic cancer will be presented at the ESMO Congress 2026. The trial investigates a novel Deep Cyclic Inhibitor designed to improve survival by shrinking tumors,…
Lululemon's share price has been punished after weak sales and a cut to guidance, leaving the stock trading at single-digit earnings multiples and near 52-week lows. The balance sheet and margins still give the company room to recover if product and inventory moves stick. We lay out a buy plan with an entry, stop, and target, plus the catalysts tha…
Palantir is showing bullish technicals, improving fundamentals and fresh government contract relevance that together argue for another upside leg. The stock trades near $191.77 with a strong MACD, rising EMAs and a growing free cash flow base. I layout a tactical long trade with entry, stop and target aligned to these drivers and explicit horizon a…
TurboGen Ltd., a developer of combined heat and power systems based on multifuel microturbines, reported financial results for the first half of 2026, highlighting a $7.2 million cash position as of June 30, supplemented by a recent $5 million private placement. The company commenced Nasdaq trading in August 2026 and is preparing for initial instal…
Microchip Technology announced new 65V digital power monitor families PAC1761 and PAC1861 designed to support growing 48V power architectures across automotive, AI/data center, networking, and industrial sectors. These devices offer enhanced voltage measurement headroom, transient spike protection, and energy-aware real-time power insights to build…
Bank of America (BAC) is an actionable long after a selloff that pushed sentiment to oversold levels. The stock trades at about $56.12 with a P/E around 12-13, a tangible dividend and improving efficiency from AI investments. This trade targets a bounce toward $64 over the next 45 trading days with a disciplined stop at $52.50.
Auddia Inc. (NASDAQ: AUUD) has adjourned its Special Meeting of Stockholders to October 7, 2026, to allow additional time for shareholders to vote on the proposed merger with Thramann Holdings. Currently, approximately 88% of votes cast support the merger, but a majority of all outstanding shares must approve the transaction. Upon completion, the c…
Ethan Allen Interiors Inc. filed its definitive proxy statement ahead of the November 4, 2026 Annual Meeting, urging shareholders to vote for its five highly qualified director nominees in response to a proxy contest instigated by 5.2% shareholder DGB Investment. The company highlights its strong five-year shareholder return of 49.1%, a debt-free b…
Cullinan Therapeutics, a clinical-stage biopharmaceutical company, announced key upcoming clinical data presentations in late 2026 for its T cell engager drug candidates targeting autoimmune diseases and cancer. Highlights include upcoming multi-dose regimen data for Velinotamig in SLE, CLN-978 in SLE, RA, and Sjögren’s disease, and updated Phase 1…
Pasqal Holding SA announced its first half 2026 financial results, highlighting 14% year-over-year revenue growth driven by a 34% increase in QPU-related services. The company advanced its quantum computing platform by scaling to over 1,000 physical qubits and expanding commercial partnerships with major players like NVIDIA, Google, and Saudi Aramc…
